Functional outcomes following ultrasound-guided botulinum toxin type A injections to reduce spastic equinovarus in adult post-stroke patients

Basit Öğe Kaydı
dc.authoridErsoy, Yuksel/0000-0002-8035-4532
dc.authoridBüyükavcı, Raikan Soydemir/0000-0002-2234-7158
dc.authoridAkturk, SEMRA/0000-0001-9960-6851;
dc.authorwosidErsoy, Yuksel/S-7503-2016
dc.authorwosidBüyükavcı, Raikan Soydemir/Q-5336-2018
dc.authorwosidAkturk, SEMRA/KTH-9105-2024
dc.authorwosidAKTÜRK, SEMRA/ABI-2757-2020
dc.contributor.authorAkturk, Semra
dc.contributor.authorBuyukavci, Raikan
dc.contributor.authorErsoy, Yuksel
dc.date.accessioned2024-08-04T20:44:21Z
dc.date.available2024-08-04T20:44:21Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: The aim of this study is to identify the effect on spasticity and walking of US-guided botulinum toxin type A (BoNT-A) injections administered to improve equinovarus walking pattern commonly observed in patients after stroke. Material and method: Twenty-three patients with post-stroke spastic equinovarus deformity were recruited. The US-guided BoNT-A injections were administered into the spastic muscles (including gastrocnemius; GK, soleus; S and tibialis posterior; TP) using a specific approach, and all of the patients were enrolled in rehabilitation programmes after the injections. Modified Ashworth Scale (MAS), Brunnstrom stage of lower limb, Functional Ambulation Score (FAS), Preferred Gait Speed (PGS) and the six-minute walk test (6MWT) were assessed at the baseline, 4 and 12 weeks after the BoNT-A injection. Results: Significant decreases in the MAS scores of the lower limb muscle (GK, S and TP) tone were measured 4 and 12 weeks after the BoNT-A injection when compared to the baseline scores (p < 0.05). In parallel with a reduction in spasticity there was an increase in 6MWT and PGS in the 4th and 12th weeks. Increases in motor improvement and functional ambulation score were ensured in the 12th week (p <0.05). Conclusion: Spastic equinovarus deformity observed in patients after stroke creates significant limitations in the patient's functional walking speed and distance. As a result, when BoNT-A injections accompanied by ultrasound to improve equinovarus deformity considering the innervation zones of the muscles with a specific approach are administered directly into the muscle at the correct point, we can say it provides hopeful results from a functional point of view. (C) 2018 Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.toxicon.2018.03.003
dc.identifier.endpage98en_US
dc.identifier.issn0041-0101
dc.identifier.pmid29530514en_US
dc.identifier.scopus2-s2.0-85043494595en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage95en_US
dc.identifier.urihttps://doi.org/10.1016/j.toxicon.2018.03.003
dc.identifier.urihttps://hdl.handle.net/11616/98192
dc.identifier.volume146en_US
dc.identifier.wosWOS:000433016800012en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofToxiconen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLower limb spasticityen_US
dc.subjectUltrasound-guided botulinum toxin injectionen_US
dc.subjectInnervation zonesen_US
dc.subjectGainen_US
dc.titleFunctional outcomes following ultrasound-guided botulinum toxin type A injections to reduce spastic equinovarus in adult post-stroke patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu